DOI: https://doi.org/10.32776/revbiomed.v31i3.840

The new normal of medical research: replicability and reproducibility

José Manuel González-Rayas, Ana Lilia Rayas-Gómez, José Manuel González-Yáñez, José Juan García-González, José Ascención Hernández-Hernández, Rosa del Carmen López-Sánchez

Resumen

Debido a que la presnete contribución es una editorial, no se cuenta con resumen.

Referencias

Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. En prensa.

Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. En prensa.

Offord C. Surgisphere Sows Confusion About Another Unproven COVID-19 Drug. The Scientist. 2020 June 16. News & Opinion. Available from: https://www. the-scientist.com/news-opinion/surgisphere-sowsconfusion-about-another-unproven-covid19-drug-67635

National Academies of Sciences, Engineering, and Medicine. Reproducibility and Replicability in Science. Washington (D C): National Academies Press; 2019.

Petersen OH. Reproducibility – again. J Physiol. 2019 Feb; 597(3): 657–8. doi: 10.1113/JP277486

Wagner PD. Cores of Reproducibility in Physiology (CORP): Advancing the corpus of physiological knowledge. J Appl Physiol. 2017 Ene; 122(1): 89–90. doi: 10.1152/japplphysiol.01046.2016

DOI: https://doi.org/10.32776/revbiomed.v31i3.840

Enlaces refback

  • No hay ningún enlace refback.